Tumour necrosis factor receptor deficiency alters anxiety-like behavioural and neuroendocrine stress responses of mice

Cytokine

Volumn 59, Issue 1, 2012, Pages 72-78

  Gimsa, Ulrike ^a   Kanitz, Ellen ^a   Otten, Winfried ^a   Tuchscherer, Margret ^a   Tuchscherer, Armin ^a   Ibrahim, Saleh M ^b  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Behaviour; HPA reactivity; Psychosocial stress; TNF receptor; Transgenic mice

Indexed keywords

CD69 ANTIGEN; CD71 ANTIGEN; CORTICOSTERONE; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ELEVATED PLUS MAZE TEST; HELPER CELL; HORMONE DETERMINATION; HORMONE SYNTHESIS; IMMUNOMODULATION; LOCOMOTION; LYMPHOCYTE ACTIVATION; MALE; MAZE TEST; MENTAL STRESS; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CD4-POSITIVE T-LYMPHOCYTES; CORTICOSTERONE; LYMPHOCYTE ACTIVATION; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROSECRETORY SYSTEMS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STRESS, PSYCHOLOGICAL;

MUS; MUS MUSCULUS;

EID: 84861705847     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.001     Document Type: Article

References (49)

1. Bernardini R., Kamilaris T.C., Calogero A.E., Johnson E.O., Gomez M.T., Gold P.W., et al. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology 1990, 126:2876-2881.
2. Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 1999, 19:5654-5665.
3. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacol 2000, 22:370-379.
4. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001, 11:203-208.
5. Palin K., Bluthe R.M., McCusker R.H., Moos F., Dantzer R., Kelley K.W. TNF-alpha-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I. J Neuroimmunol 2007, 187:55-60.
6. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998, 84:923-933.
7. Turnbull A.V., Pitossi F.J., Lebrun J.J., Lee S., Meltzer J.C., Nance D.M., et al. Inhibition of tumor necrosis factor-alpha action within the CNS markedly reduces the plasma adrenocorticotropin response to peripheral local inflammation in rats. J Neurosci 1997, 17:3262-3273.
8. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001, 11:372-377.
9. Vandenabeele P., Declercq W., Beyaert R., Fiers W. 2 Tumor-Necrosis-Factor receptors - structure and function. Trends Cell Biol 1995, 5:392-399.
10. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002, 14:477-492.
11. Matsumoto M. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting. J Med Invest 1999, 46:141-150.
12. Le H.M., Bluethmann H., Kosco-Vilbois M.H., Muller M., Di P.F., Moore M., et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J Exp Med 1996, 183:2367-2372.
13. Pasparakis M., Alexopoulou L., Grell M., Pfizenmaier K., Bluethmann H., Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55kDa receptor. Proc Natl Acad Sci USA 1997, 94:6319-6323.
14. Merlot E., Moze E., Dantzer R., Neveu P.J. Cytokine production by spleen cells after social defeat in mice. activation of T cells and reduced inhibition by glucocorticoids. Stress 2004, 7:55-61.
15. Stefanski V. Social stress in loser rats: opposite immunological effects in submissive and subdominant males. Physiol Behav 1998, 63:605-613.
16. Bailey M.T., Kinsey S.G., Padgett D.A., Sheridan J.F., Leblebicioglu B. Social stress enhances IL-1beta and TNF-alpha production by Porphyromonas gingivalis lipopolysaccharide-stimulated CD11b+ cells. Physiol Behav 2009, 98:351-358.
17. Yamada K., Iida R., Miyamoto Y., Saito K., Sekikawa K., Seishima M., et al. Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior. J Neuroimmunol 2000, 111:131-138.
18. Quintana A., Molinero A., Florit S., Manso Y., Comes G., Carrasco J., et al. Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: from gene to behavior. J Neurosci Res 2007, 85:2668-2685.
19. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNF-alpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006, 59:775-785.
20. Palin K., Bluthe R.M., McCusker R.H., Levade T., Moos F., Dantzer R., et al. The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNF-alpha-induced sickness behavior. Psychopharmacology 2009, 201:549-556.
21. Palin K., McCusker R.H., Strle K., Moos F., Dantzer R., Kelley K.W. Tumor necrosis factor-alpha-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase. Psychopharmacology 2008, 197:629-635.
22. Taraborrelli C., Palchykova S., Tobler I., Gast H., Birchler T., Fontana A. TNFR1 is essential for CD40, but not for lipopolysaccharide-induced sickness behavior and clock gene dysregulation. Brain Behav Immun 2010.
23. Patel A., Siegel A., Zalcman S.S. Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 2010, 24:1276-1280.
24. Rousselet E., Callebert J., Parain K., Joubert C., Hunot S., Hartmann A., et al. Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp Neurol 2002, 177:183-192.
25. Kinsey S.G., Bailey M.T., Sheridan J.F., Padgett D.A., Avitsur R. Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain Behav Immun 2007, 21:458-466.
26. Belzung C., Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 2001, 125:141-149.
27. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur J Immunol 1999, 29:626-632.
28. Gimsa U., Kanitz E., Otten W., Ibrahim S.M. Behavior and stress reactivity in mouse strains with mitochondrial DNA variations. Ann NY Acad Sci 2009, 1153:131-138.
29. Fiore M., Alleva E., Probert L., Kollias G., Angelucci F., Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol Behav 1998, 63:571-576.
30. Petitto J.M., McNamara R.K., Gendreau P.L., Huang Z., Jackson A.J. Impaired learning and memory and altered hippocampal neurodevelopment resulting from interleukin-2 gene deletion. J Neurosci Res 1999, 56:441-446.
31. Lacosta S., Merali Z., Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav Neurosci 1999, 113:1030-1041.
32. Neta R., Sayers T.J., Oppenheim J.J. Relationship of TNF to interleukins. Immunol Ser 1992, 56:499-566.
33. Perez A.R., Roggero E., Nicora A., Palazzi J., Besedovsky H.O., Del R.A., et al. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 2007, 21:890-900.
34. Tynan R.J., Naicker S., Hinwood M., Nalivaiko E., Buller K.M., Pow D.V., et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 2010, 24:1058-1068.
35. Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007, 21:47-59.
36. Sugama S., Takenouchi T., Fujita M., Conti B., Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 2009, 207:24-31.
37. Sugama S., Takenouchi T., Fujita M., Kitani H., Hashimoto M. Cold stress induced morphological microglial activation and increased IL-1beta expression in astroglial cells in rat brain. J Neuroimmunol 2010.
38. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immune effector cell of the brain. Brain Res Brain Res Rev 1995, 20:269-287.
39. Chung I.Y., Benveniste E.N. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol 1990, 144:2999-3007.
40. Hara T., Jung L.K., Bjorndahl J.M., Fu S.M. Cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med 1986, 164:1988-2005.
41. Cebrian M., Yague E., Rincon M., Lopez-Botet M., de Landazuri M.O., Sanchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988, 168:1621-1637.
42. Nakamura S., Sung S.S., Bjorndahl J.M., Fu S.M. Cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1. J Exp Med 1989, 169:677-689.
43. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J Immunol 1989, 143:1123-1128.
44. Santis A.G., Campanero M.R., Alonso J.L., Tugores A., Alonso M.A., Yague E., et al. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur J Immunol 1992, 22:1253-1259.
45. Mori L., Iselin S., De L.G., Lesslauer W. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J Immunol 1996, 157:3178-3182.
46. Evangelidou M., Tseveleki V., Vamvakas S.S., Probert L. TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses. Immunol Cell Biol 2010, 88:586-595.
47. Dhabhar F.S. Stress-induced augmentation of immune function-the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 2002, 16:785-798.
48. Fleshner M., Nguyen K.T., Cotter C.S., Watkins L.R., Maier S.F. Acute stressor exposure both suppresses acquired immunity and potentiates innate immunity. Am J Physiol 1998, 275:R870-R878.
49. Bailey M.T., Engler H., Powell N.D., Padgett D.A., Sheridan J.F. Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1180-R1190.